RBC Europe’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,680
| Closed | -$57.5K | – | 1250 |
|
|
2021
Q2 | $57.5K | Hold |
2,680
| – | – | ﹤0.01% | 560 |
|
|
2021
Q1 | $52.8K | Hold |
2,680
| – | – | ﹤0.01% | 542 |
|
|
2020
Q4 | $52.9K | Hold |
2,680
| – | – | ﹤0.01% | 502 |
|
|
2020
Q3 | $47.1K | Hold |
2,680
| – | – | ﹤0.01% | 469 |
|
|
2020
Q2 | $48.1K | Hold |
2,680
| – | – | ﹤0.01% | 452 |
|
|
2020
Q1 | $40.1K | Hold |
2,680
| – | – | ﹤0.01% | 425 |
|
|
2019
Q4 | $46.7K | Hold |
2,680
| – | – | ﹤0.01% | 466 |
|
|
2019
Q3 | $40.5K | Hold |
2,680
| – | – | ﹤0.01% | 480 |
|
|
2019
Q2 | $45.2K | Hold |
2,680
| – | – | ﹤0.01% | 482 |
|
|
2019
Q1 | $45.9K | Hold |
2,680
| – | – | 0.01% | 482 |
|
|
2018
Q4 | $40.5K | Buy |
2,680
+430
| +19% | +$6.5K | 0.01% | 479 |
|
|
2018
Q3 | $45.9K | Hold |
2,250
| – | – | 0.01% | 496 |
|
|
2018
Q2 | $42.3K | Buy |
2,250
+1,340
| +147% | +$25.2K | 0.01% | 502 |
|
|
2018
Q1 | $17.5K | Hold |
910
| – | – | ﹤0.01% | 703 |
|
|
2017
Q4 | $17.9K | Buy |
910
+350
| +63% | +$6.87K | ﹤0.01% | 706 |
|
|
2017
Q3 | $12K | Buy |
+560
| New | +$12K | ﹤0.01% | 791 |
|